Literature DB >> 34059017

Hematological indices and abnormalities among patients with uncomplicated falciparum malaria in Kosti city of the White Nile state, Sudan: a comparative study.

Ahmed M E Elkhalifa1,2, Rashad Abdul-Ghani3,4, Abdelhakam G Tamomh5, Nur Eldin Eltaher6, Nada Y Ali2, Moataz M Ali7,8, Elsharif A Bazie9, Aboagla KhirAlla2, Fatin A DfaAlla2, Omnia A M Alhasan2.   

Abstract

BACKGROUND: Hematological abnormalities are common features in falciparum malaria but vary among different populations across countries. Therefore, we compared hematological indices and abnormalities between Plasmodium falciparum-infected patients and malaria-negative subjects in Kosti city of the White Nile State, Sudan.
METHODS: A comparative, cross-sectional study was conducted at the Clinical Laboratory Unit of Kosti Teaching Hospital from June to December 2018. A total of 392 participants (192 P. falciparum-infected patients and 200 malaria-negative subjects) were recruited in the study. Hematological indices of hemoglobin (Hb), red blood cells (RBCs), white blood cells (WBCs) and platelets were measured, and their median values were statistically compared.
RESULTS: The majority of P. falciparum-infected patients (67.6%) showed a low-level parasitemia. The median values of Hb concentration, RBC count, mean corpuscular volume (MCV), mean corpuscular Hb (MCH) and mean corpuscular Hb concentration (MCHC) were significantly lower in P. falciparum-infected patients, while the median red cell distribution width (RDW) was significantly higher in the patients compared to malaria-negative subjects. Anemia, low MCV, low MCH, low MCHC and high RDW were significantly associated with falciparum malaria, but parasitemia level was not significantly associated with anemia severity. The median total WBC count was non-significantly higher in P. falciparum-infected patients, with neutropenia being significantly associated with falciparum malaria. The median platelet count was significantly lower in P. falciparum-infected patients, with thrombocytopenia being significantly associated with falciparum malaria.
CONCLUSIONS: Falciparum malaria among patients in Kosti city of the White Nile State, Sudan is predominantly of low-level parasitemia. It is significantly associated with anemia, low MCV, low MCH, low MCHC, high RDW, thrombocytopenia and neutropenia. However, parasitemia level is not a significant predictor of anemia severity. On the other hand, leucopenia is not useful to predict falciparum malaria. Further large-scale studies in community and healthcare settings and inclusion of patients with complicated or severe malaria and those with high parasite densities are recommended.

Entities:  

Keywords:  Anemia; Falciparum malaria; Hematological indices; MCH; MCHC; MCV; Neutropenia; RDW; Sudan; Thrombocytopenia

Year:  2021        PMID: 34059017     DOI: 10.1186/s12879-021-06228-y

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  33 in total

Review 1.  Thrombocytopenia in malaria: who cares?

Authors:  Marcus Vinícius Guimarães Lacerda; Maria Paula Gomes Mourão; Helena Cristina Cardoso Coelho; João Barberino Santos
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

2.  Haematological parameters, haemozoin-containing leukocytes in Sudanese children with severe Plasmodium falciparum malaria.

Authors:  Magdi M Salih; Hatim G Eltahir; Tajeldin M Abdallah; Tariq E Elmahdi; Ammar H Khamis; Elfatih E Malik; Ishag Adam
Journal:  J Infect Dev Ctries       Date:  2018-04-30       Impact factor: 0.968

Review 3.  Malaria Pathogenesis.

Authors:  Danny A Milner
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

4.  Effect of Plasmodium falciparum infection on blood parameters and their association with clinical severity in adults of Odisha, India.

Authors:  Gunanidhi Dhangadamajhi; Subhendu Panigrahi; Shaktirekha Roy; Sagnika Tripathy
Journal:  Acta Trop       Date:  2018-10-19       Impact factor: 3.112

5.  A systematic analysis of global anemia burden from 1990 to 2010.

Authors:  Nicholas J Kassebaum; Rashmi Jasrasaria; Mohsen Naghavi; Sarah K Wulf; Nicole Johns; Rafael Lozano; Mathilda Regan; David Weatherall; David P Chou; Thomas P Eisele; Seth R Flaxman; Rachel L Pullan; Simon J Brooker; Christopher J L Murray
Journal:  Blood       Date:  2013-12-02       Impact factor: 22.113

6.  Prevalence of anaemia among Quranic school (Khalawi) students (Heiran)in Wad El Magboul village, rural Rufaa, Gezira State, Central Sudan: a cross sectional study.

Authors:  Mohammed Saeed Elsamani Eltayeb; Awad Eseed Elsaeed; Ahmed Abdalla Mohamedani; Abbas Abdalrahman Assayed
Journal:  Pan Afr Med J       Date:  2016-07-15

7.  Plasmodium vivax cerebral malaria in an adult patient in Sudan.

Authors:  Maowia M Mukhtar; Omer A Eisawi; Seth A Amanfo; Elwaleed M Elamin; Zeinab S Imam; Faiza M Osman; Manasik E Hamed
Journal:  Malar J       Date:  2019-09-18       Impact factor: 2.979

8.  Aspartate aminotransferase-to-platelet ratio index (APRI): A potential marker for diagnosis in patients at risk of severe malaria caused by Plasmodium vivax.

Authors:  Karla Sena Guedes; Bruno Antônio Marinho Sanchez; Luciano Teixeira Gomes; Cor Jesus Fernandes Fontes
Journal:  PLoS One       Date:  2019-11-25       Impact factor: 3.240

9.  Effect of malarial infection on haematological parameters in population near Thailand-Myanmar border.

Authors:  Manas Kotepui; Bhukdee Phunphuech; Nuoil Phiwklam; Chaowanee Chupeerach; Suwit Duangmano
Journal:  Malar J       Date:  2014-06-05       Impact factor: 2.979

Review 10.  Anaemia and malaria.

Authors:  Nicholas J White
Journal:  Malar J       Date:  2018-10-19       Impact factor: 2.979

View more
  1 in total

1.  Genome-Wide Association Study on the Hematological Phenotypic Characteristics of the Han Population from Northwest China.

Authors:  Wei Yang; Xue He; Yuying Yao; Hongyan Lu; Yuliang Wang; Zhanhao Zhang; Yuhe Wang; Li Wang; Yongjun He; Dongya Yuan; Tianbo Jin
Journal:  Pharmgenomics Pers Med       Date:  2022-08-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.